Our next Undoing Aging 2018 video features Dr. Mike West, founder and CEO of AgeX Therapeutics, who presented their work on induced tissue regeneration - leveraging the unique regenerative potential of pluripotent stem-cell-derived therapeutics.

AgeCurve founder Attila Csordas' presentation at Undoing Aging 2018 explained how their direct-to-consumer proteomics platform can help clients to understand their personal aging process at the molecular level, as well as the impact of novel therapies.

A new article in luxury industry magazine Luxe Digital profiles SENS Research Foundation and discusses the potential for rejuvenation biotechnology to comprehensively repair the damage caused by aging, thus preventing the diseases of old age.

Dr. Brian Kennedy's presentation at Undoing Aging 2018 looked back over the history of research into healthy life extension in animals and humans, before introducing Singapore's current efforts to become a global leader in the field.

The Longevity Industry Landscape Overview 2018 is a 650 page analytical report which charts the markets, trends and sectors of the emerging healthy life extension industry, including profiles of major companies and investors.

In the second video from Undoing Aging 2018, Antoxerene CSO Adam Blanden discusses how their innovative protein engineering techniques are being employed to develop new classes of diagnostics and drugs for age-related disease.

Co-authored by futurists José Luis Cordeiro and David Wood, and with a foreword by Dr. de Grey, La Muerte de la Muerte (in Spanish) emphasises the feasibility and moral urgency of defeating age-related disease - with proceeds being donated to SRF. Also available on Amazon!

San Francisco Chronicle Editor in Chief Audrey Cooper moderates a lively discussion between SRF CSO Aubrey de Grey and William Hurlburt, Adjunct Professor at the Stanford Medical School, centered around the medical potential and ethical implications of living forever.

Check out all the latest news from SENS Research Foundation in our May newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

Our new Annual Report, covering accomplishments in 2017 and over the first part of this year, has now been released!  It's packed with information on our research projects, education programs, and outreach activities.

SRF Research Advisory Board member and long-time supporter Professor Judy Campisi has been elected to the National Academy of Sciences - the highest honor for American scholars - in recognition of her work on senescent cells and their role in age-related disease.

SRF CSO Dr. Aubrey de Grey gave a presentation at the Block2TheFuture cryptocurrency conference in April 2018. As well as his main talk, linked below, a video of the Q&A session with Aubrey and Dr. Katakowski of Forever Labs is also available.

In this short clip from BBC Click, SENS Research Foundation CSO Dr. Aubrey de Grey explains the essential principle of our work: thoroughly repairing the damage that builds up within the body over the course of life will completely prevent the diseases that now plague the elderly.

In his rare moments of spare time, SRF CSO Dr. Aubrey de Grey enjoys working on mathematical problems as well as age-related ones. Quanta Magazine explains how one of his recent papers has made the first progress in decades on a famous graph theory question.

A selection of the talks from Undoing Aging 2018 will be shared over the coming weeks as we receive clearance from the speakers. First up: Lysoclear CEO Kelsey Moody, presenting their SENS-inspired approach to combating age-related macular degeneration (AMD).

In cooperation with the Forever Healthy Foundation, SRF is inviting candidates to submit research proposals for a three-year Fellowship in Rejuvenation Biotechnology at our Research Center in California. The deadline for initial applications is May 15th 2018.

We're seeking a full-time researcher for a Scientist I position at our Research Center in California, to lead a new intramural research project performing translational research studying aging as it relates to the immune system.